Summary
The latest offers from the National Institute for Health and Care Research (NIHR) are available.
General practice can take part in various ‘light touch’ studies.
The LOLIPOP 100k Study (South Asia Biobank) – South Asians living in the UK are at high risk of both cardiovascular disease and type-2 diabetes. The mechanisms are not known. To advance understanding of metabolic, cardiovascular and other important chronic diseases in UK South Asians, the study team are proposing to establish LOLIPOP 100k, a longitudinal population study compromising 100,000 South Asian men and women, aged 18-85 years, under long-term follow-up for health outcomes. If you’d like to find out more please see this video about the study on YouTube.
The DISCOVER ME study – More and more GP practices across GM are taking part in the Discover Me study, offering their patients the opportunity to find out their ancestry as well as contribute to creating a dynamic research resource to help us understand disease susceptibility and severity.
The BRIT2 study – Researchers at the University of Manchester have developed a series of dashboards for EMIS that uses data from GP practices to help understand where to focus efforts to optimise prescribing. Software is downloaded to the practice system and anonymous data is viewed by the study team, but the practice team can view identifiable information and use it to inform prescribing.
A paper called ‘Primary and Secondary Care Collaboration in Clinical Research’ has recently been published in the Future Healthcare Journal. The paper demonstrates the breadth of primary care research recruitment and delivery options.
National Contract Value Review (NCVR) – represents an opportunity for general practices to increase their involvement in life science industry studies, which in turn could improve participant access to research. The UK strives to be the only country in the world with a truly single commercial costing and contracting process which spans both primary and secondary care. As independent contractors, GP practices are not required to adhere to the prices generated by the interactive Costing Tool (iCT) for commercial contract research.
However, a scheme has been created to enable GP practices to voluntarily commit to NCVR and single negotiations. This will enable practices to benefit from the efficiency in study start up and business development opportunities generated by the programme.
What does signing up mean for my GP practice?
By signing up, you are agreeing to:
- No negotiation on any commercial contract study that has had a national resource review conducted by an NHS Costing Expert using the iCT.
- Using the Health Research Authority (HRA)’s unmodifiable Clinical Trials Agreement and associated unmodifiable financial appendix.
- Holding this position for a minimum of 12 months.
Where can I get more information about the programme?
- NIHR Website – Faster Costing and Contracting
- NHS England Website – Programme level information regarding NCVR
- Speak to your local Clinical Research Network Industry Team
A full list of all available studies in general practice can be found on the NIHR Primary Care Research Hub.
